DE   EN   ES   FR   IT   PT


medicalmeds.eu Medicines Peripheral vazodilatator. Pilfud

Pilfud

Препарат Пилфуд. Bosnalijek (Босналек) Республика Босния-Герцеговина


Producer: Bosnalijek (Bosnalek) Republic Bosnia-Herzegovina

Code of automatic telephone exchange: D11AX01

Release form: Liquid dosage forms. Lotion.

Indications to use: Alopecia.


General characteristics. Structure:

Active ingredient: minoxidil; 1 ml of lotion contains a minoksidil of 20 mg;

excipients: ethanol of 96%, propylene glycol, the water purified.




Pharmacological properties:

Minoksidil is a strong peripheral vazodilatator which influences smooth muscles of blood vessels. When drawing on head skin minoksidit stimulates a growth recovery of hair at patients with an alopecia on men's type. The mechanism of an intensification of growth of hair is in what at topical administration minoksidit promotes strengthening of blood circulation in head skin, to improvement of providing with nutrients that the follicle leads to recovery atrophied hair.

Growth of hair is usually observed after 2-4 months of therapy.

At topical administration of lotion through the unimpaired head skin the insignificant quantity of a minoksidil is soaked up (to 4,5%). Absorption of a minoksidil by skin amplifies at increase in a dosage, frequency or the surface of use of lotion. Metabolism of the absorbed minoksidil happens in a liver, allocation of a minoksidil and its metabolites - mainly through kidneys. After the end of topical treatment of 95% of a minoksidil it is removed within 4 days.


Indications to use:

Alopecia on men's type at women and men.


Route of administration and doses:

Lotion Pilfud Bosnalek is intended only for external use to men and women there are from 18 to 65 years.

Using the injektor enclosed in packaging to put on 1 ml of lotion Pilfud Bosnalek 2% for dry skin in a baldness zone 2 times a day and it is easy to rub from the center to the periphery of the site. The daily dose should not exceed 2 ml of lotion. After achievement of clinical improvement the dose can be reduced to supporting - 1 ml of lotion 1-2 times a week.

Duration of therapy depends on its results, usually the course makes 4 months.


Features of use:

Use during pregnancy or feeding by a breast.
During pregnancy and feeding by a breast it is contraindicated to women to use drug.

Ability to influence speed of response at control of motor transport or work with other mechanisms.
Does not influence.

Children.
Do not appoint drug to children aged up to 18 years

Special use.

It is not necessary to exceed a dose and frequency of use of lotion as it can lead to emergence of side effects.

After each use of lotion it is necessary to wash up hands.

At hit of drug on mucous membranes, the injured skin, in eyes it is necessary to wash out carefully these sites flowing water.

During treatment the phenom as it can cause the accelerated evaporation of active agent is not recommended to use.

It is necessary to apply with care sick with coronary heart disease, stenocardia, arrhythmia, to patients with arterial hypotension in connection with possible systemic action of a minoksidil.

In case of lack of satisfactory result in 4 months consultation of the dermatologist is necessary. Continuation of a course or repeated treatment is recommended after consultation of the dermatologist.

Drug flammable, after opening of original packaging drug it is necessary to protect from naked flame and high temperatures.


Side effects:

Minoksidil at topical administration is usually well had. Such side reactions in an injection site are in some cases possible: contact dermatitis, a diffusion hypertrichosis, a xeroderma, local reddening, an itch, allergic skin reactions, irritation of skin with the advent of an acne, a local photosensitization, strengthening of a hair loss, discoloration and textures of hair, a head skin dyschromia.

System side effects arise in rare instances (usually at disturbance of the mode of dosing or when drawing on a big surface) and include: a headache, dizziness, a lowering of arterial pressure, tachycardia, the hypostases caused by a delay of sodium and water, sexual dysfunction, decrease in visual acuity.


Interaction with other medicines:

Simultaneous use of drug Pilfud Bosnalek and other drugs for topical administration, the containing corticosteroids, третионин, дитранол or vaseline, can strengthen absorption of a minoksidil. Strengthening of orthostatic hypotension at absorption of a minoksidil at patients who accept гуанетидин though clinically it is not confirmed is possible.


Contraindications:

Hypersensitivity to components of drug, a head skin disease (including psoriasis and sunblisters), simultaneous use on head skin of other drugs for topical administration; pheochromocytoma, arterial hypertension, period of pregnancy and feeding by a breast; age of the patient less than 18 or more 65 years.


Overdose:

Overdose cases at topical administration of lotion Pilfud Bosnalek 2% are not described.

Accidental hit of lotion in a digestive tract can cause the system effects caused by vasodilating action of a minoksidil. It can be the cardiovascular disturbances which are followed by arterial hypotension, a delay of liquid and tachycardia.

At tachycardia beta-blockers are appointed. For correction of a delay of liquid diuretics. Arterial hypotension is possible it is treated by intravenous administration of normal saline solution.


Storage conditions:

Period of validity. 3 years. To store in the place, unavailable to children, at a temperature not above 25 °C. Not to freeze.


Issue conditions:

Without recipe


Packaging:

On 60 ml in a bottle, after 1 bottle and 1 injektor in a cardboard box.



Similar drugs

Препарат Генеролон. Bosnalijek (Босналек) Республика Босния-Герцеговина

Generolon

Remedy for an alopecia.



Препарат Косилон® 5%. Bosnalijek (Босналек) Республика Босния-Герцеговина

È«ß¿½«¡® 5%

Vazodilatiruyushchy means.



Препарат Косилон® 2%. Bosnalijek (Босналек) Республика Босния-Герцеговина

È«ß¿½«¡® 2%

Vazodilatiruyushchy means.





  • Сайт детского здоровья